Published in J Virol on December 01, 1981
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
Heterogeneity of the human papillomavirus group. J Virol (1989) 4.90
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J (1988) 3.61
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43
Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol (1986) 2.93
Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata. J Virol (1987) 2.57
Transient replication of human papillomavirus DNAs. J Virol (1992) 2.43
The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol (1990) 2.19
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A (1982) 2.11
Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes. J Virol (1983) 2.01
Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc Natl Acad Sci U S A (1989) 1.87
Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ (1989) 1.84
Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol (1989) 1.80
Identification of a transforming gene of human papillomavirus type 16. J Virol (1989) 1.75
Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. J Virol (1988) 1.63
Sensitive in situ hybridisation technique using biotin-streptavidin-polyalkaline phosphatase complex. J Clin Pathol (1987) 1.56
Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol (1989) 1.53
In situ hybridization analysis of HPV 16 DNA sequences in early cervical neoplasia. Am J Pathol (1986) 1.48
Human papillomavirus genome variants. Virology (2013) 1.45
Human papillomaviruses: are we ready to type? Clin Microbiol Rev (1989) 1.37
Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol (1986) 1.32
Human papillomaviruses in anogenital warts in children: typing by in situ hybridisation. BMJ (1990) 1.29
Characterization of human papillomavirus type 13 from focal epithelial hyperplasia Heck lesions. J Virol (1983) 1.28
Identification of the human papillomavirus type 6b L1 open reading frame protein in condylomas and corresponding antibodies in human sera. J Virol (1987) 1.26
Interphase cytogenetics using biotin and digoxigenin labelled probes II: Simultaneous differential detection of human and papilloma virus nucleic acids in individual nuclei. J Clin Pathol (1989) 1.25
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia. J Virol (1989) 1.21
Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. J Virol (1989) 1.20
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J (2002) 1.14
In situ hybridisation with digoxigenin-labelled DNA probes for detection of viral genomes. J Clin Pathol (1990) 1.10
Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol (1990) 1.09
Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J Virol (1992) 1.03
Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J Virol (1991) 1.01
p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens. Diagn Pathol (2009) 1.00
Transcriptional regulatory elements in the noncoding region of human papillomavirus type 6. J Virol (1988) 0.99
Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J Virol (1997) 0.98
Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas. J Virol (1995) 0.96
Characterization of a new type of human papillomavirus found in a lesion of Bowen's disease of the skin. J Virol (1986) 0.96
Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. J Virol (1992) 0.95
Human papillomavirus in oesophageal squamous cell carcinoma. J Clin Pathol (1990) 0.94
Prevalence of low and high risk human papillomavirus types in cervical cells from Hong Kong pregnant Chinese using filter in situ hybridization. Arch Gynecol Obstet (1991) 0.87
Alterations in the regulatory region of the human papillomavirus type 6 genome are generated during propagation in Escherichia coli. J Virol (1988) 0.86
Detection of viral DNA by in situ hybridization using bromodeoxyuridine-labeled DNA probes. Am J Pathol (1988) 0.86
Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines. J Clin Pathol (1991) 0.85
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev (2012) 0.84
Presence of human papillomavirus type-6-related sequences in inverted nasal papillomas. Eur Arch Otorhinolaryngol (1990) 0.80
Viruses, Other Pathogenic Microorganisms and Esophageal Cancer. Gastrointest Tumors (2015) 0.79
Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas. J Virol (2012) 0.79
Human papillomavirus induced transformation in cervical and head and neck cancers. Cancers (Basel) (2014) 0.79
Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells. J Virol (1990) 0.79
Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer. J Oncol (2015) 0.77
Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis. Clin Microbiol Rev (1991) 0.77
Human papillomavirus type 6 long control region and human cellular DNA contain related sequences. J Virol (1990) 0.77
Molecular cloning and characterization of a new subtype of human papillomavirus 6 DNA. Eur Arch Otorhinolaryngol (1991) 0.75
Next generation sequencing and its applications in HPV-associated cancers. Oncotarget (2016) 0.75
Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis. PLoS One (2015) 0.75
Tristetraprolin: a weapon against HPV-induced cervical cancer? Aging (Albany NY) (2009) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A (1978) 19.34
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences. J Virol (1980) 3.34
Human papilloma viruses (HPV): characterization of four different isolates. Virology (1977) 2.99
Characterization of a new type of human papillomavirus that causes skin warts. J Virol (1977) 2.94
Anogenital warts contain several distinct species of human papillomavirus. J Virol (1980) 2.23
The isolation of DNA from agarose gels by electrophoretic elution onto malachite green-polyacrylamide columns. Gene (1978) 2.05
Oncogenic Herpes viruses. Biochim Biophys Acta (1975) 2.01
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. Eur J Biochem (1980) 1.64
The absence of human papilloma viral DNA sequences in condylomata acuminata. Virology (1976) 1.48
Viral sequences related to a human skin papillomavirus in genital warts. Nature (1978) 1.39
Mutants of adenovirus type 12 after adaptation to growth in tumor cell lines. II. Reproducible acquisition of additional sequences after adaptation to a human cervical cancer line. Int J Cancer (1981) 1.02
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature (1978) 9.25
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet (1982) 4.31
Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer (1982) 4.30
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene (1987) 4.02
Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (1987) 3.70
Human papilloma viruses (HPV): characterization of four different isolates. Virology (1977) 2.99
Human papillomaviruses. Annu Rev Microbiol (1994) 2.88
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Condylomata acuminata and human genital cancer. Cancer Res (1976) 2.67
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J Virol (1985) 2.56
Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A (1979) 2.55
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology (1984) 2.49
A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene (1984) 2.44
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A (1987) 2.40
Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology (1970) 2.39
DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res (1988) 2.39
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology (1986) 2.26
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Lymphotropic papovaviruses isolated from African green monkey and human cells. Med Microbiol Immunol (1979) 2.23
Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells. J Virol (1984) 2.23
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology (1984) 2.13
Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer (1987) 2.03
Oncogenic Herpes viruses. Biochim Biophys Acta (1975) 2.01
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol (1990) 2.00
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer (1974) 1.98
Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol (1987) 1.97
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV. Intervirology (1980) 1.92
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res (1988) 1.89
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. Virology (1979) 1.85
Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet (1986) 1.82
Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol (1984) 1.80
Human papilloma virus DNA: physical mapping and genetic heterogeneity. Proc Natl Acad Sci U S A (1976) 1.76
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J (1992) 1.74
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol (1998) 1.72
Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer (1985) 1.71
Papillomaviruses in human cancer. Cancer (1987) 1.71
B-lymphotropic papovavirus and possibility of infections in humans. J Med Virol (1981) 1.68
Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol (1987) 1.67
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology (1997) 1.66
Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology (1992) 1.64
Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames. Virology (1994) 1.63
Genital papillomavirus infections. Prog Med Virol (1985) 1.58
Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54
Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol (1998) 1.54
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome. J Virol (1989) 1.52
Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res (1994) 1.51
Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Int J Cancer (1978) 1.49
Do specific human papillomavirus types cause psoriasis? Arch Dermatol (2001) 1.48
Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol (1985) 1.47
Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol (1999) 1.46
[Detection of DNA of human papillomaviruses (HPV) in an "aggressively" growing cholesteatoma. Is cholesteatoma a virus-induced tumor?]. HNO (1995) 1.43
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol (1985) 1.42
Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer (1988) 1.37
Propagation of B-lymphotropic papovavirus (LPV) in human B-lymphoma cells and characterization of its DNA. Virology (1981) 1.37
Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer (1989) 1.34
Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum Gene Ther (2000) 1.34
Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation. Virology (1980) 1.34
Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation. Int J Cancer (1975) 1.33